Cargando…
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Five years ago, we reported the identification and characterization of several regulatory T-cell epitopes (now called Tregitopes) that were discovered in the heavy and light chains of IgG (De Groot et al. Blood, 2008). When added ex vivo to human PBMCs, these Tregitopes activated regulatory T cells...
Autores principales: | De Groot, Anne S., Cousens, Leslie, Mingozzi, Federico, Martin, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886585/ https://www.ncbi.nlm.nih.gov/pubmed/24454476 http://dx.doi.org/10.1155/2013/493138 |
Ejemplares similares
-
Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?
por: Sordé, Laetitia, et al.
Publicado: (2017) -
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
por: Cousens, Leslie P., et al.
Publicado: (2012) -
Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
por: Elyaman, Wassim, et al.
Publicado: (2011) -
Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction
por: De Groot, Anne S., et al.
Publicado: (2019) -
Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes
por: Cousens, Leslie P., et al.
Publicado: (2013)